Tag: study

Revolutionizing Cancer Diagnostics

Maryssa Gordon

Reading Time: < 1 minute Cergentis, a genomics company that develops and commercializes kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, announced the completion of a successful analytical validation study in lymphoma to show the benefits of TLA for the detection of clinically relevant translocations in tumor biopsies. The results of this study, performed in collaboration with researchers from Hubrecht Institute and lymphoma experts of 5 Dutch pathology labs (UMCU, Amsterdam UMC, UMCG, LUMC, and LabPON), have now been published in Nature Communications. The FFPE-TLC approach promises to revolutionize lymphoma diagnostics and…

Read More

Remdesivir Shows Positive Results in Treating COVID-19

DMUSA

Reading Time: 4 minutes Press Release courtesy of BusinessWire. The New England Journal of Medicine(NEJM) today published the final results from the National Institute of Allergy and Infectious Diseases’ (NIAID) double-blind, placebo-controlled, Phase 3 ACTT-1 trial of Gilead’s (Nasdaq: GILD) investigational antiviral Veklury® (remdesivir) for the treatment of adults hospitalized with mild-moderate or severe COVID-19. The final ACTT-1 study results build on the preliminary results published in NEJM in May 2020, showing that treatment with Veklury resulted in consistent, clinically meaningful improvements across multiple outcome assessments compared with placebo in COVID-19 patients. The final results demonstrate that treatment…

Read More